You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:恆科指7連跌,創新藥熄火,穩定幣概念重挫!

8月1日,港股迎開門黑行情,三大指數近日來連續回調,市場情緒表現低迷。

截止收盤,恆生指數跌1.07%,國企指數跌0.88%,二者均錄得4連跌,恆生科技指數跌1.02%更是錄得7連跌行情。

盤面上,大型科技股漲跌各異,大金融股(銀行、保險、券商)、中字頭等權重多數表現低迷;生物醫藥股全線下跌,創新藥概念股跌幅明顯,石油股走低。紙業股逆勢走強;反內卷驅動提價預期升溫,物流股全天表現活躍,汽車股、黃金股、半導體股部分上漲。

具體來看:

科技股漲跌不一,快手跌超3%,嗶哩嗶哩、騰訊跌超2%,網易、京東等跟跌;百度、阿里跌超1%。

加密貨幣、穩定幣概念重挫,耀才證券金融跌超19%,雲鋒金融跌16%,連連數字跌超13%,國泰君安國際跌超10%。消息面上,香港《穩定幣條例草案》8月1日正式生效。早前,香港金管局7月29日披露了穩定幣牌照監管一系列制度。中信證券點評稱,首批香港穩定幣牌照申請時限爲9月末,略慢於預期。

生物醫藥、創新藥、醫藥外包概念跌幅居前,復宏漢霖、藥明康德、藥明合聯、君實生物、泰格醫藥等跌超3%。消息面上,美國總統特朗普週四表示,他已致信包括輝瑞、諾和諾德、強生在內的17家大型製藥公司,要求其在未來60天內採取具體行動,降低美國藥品價格,否則將動用“一切可用手段”保護美國家庭免受“藥價暴利”的影響。另外,日前國家醫保局方面首次對外公開“新上市藥品首發價格機制”已經制定,中國創新藥或邁向定價新週期。

物流股漲幅居前,粵運交通漲超8%,中通快遞-W漲超7%。“反內卷”政策驅動快遞行業提價預期升溫。近期國家郵政局密集召開會議,明確要求快遞企業“旗幟鮮明反對內卷式競爭”,整治末端服務質量問題,並強調企業總部需履行主體責任,創新經營模式,保障基層網點穩定與農村服務可持續性。

紙業股走強,綜合環保集團漲超6%,玖龍紙業漲超3%,理文造紙、晨鳴紙業等跟漲。個股消息面上,消息面上,近日玖龍紙業60億元林漿紙一體化智能工廠項目正式簽約重慶樞紐港產業園。

個股方面,英諾賽科午後暴拉,盤中最高漲超63%,市值一度突破600億港元,最終收漲30.91%報57.6港元。消息面上,英偉達官網今日更新800V直流電源架構合作商名錄,英諾賽科是本次入選英偉達合作夥伴中唯一的中國芯片企業。

今日,南向資金淨買入122.07億港元.其中,港股通(滬)淨買入55.75億港元,港股通(深)淨買入66.32億港元。

展望後市,高盛首席中國股票策略分析師劉勁津表示,當前股市的估值已不再低廉,指數在連續刷新年內新高後,出現回調在所難免。但隨着企業盈利的改善,在未來12個月,中國股市還會有10%~15%的增長空間

中信證券稱,預計港股2025年中期業績將於8月中下旬集中發佈。按當前已有盈利預期的公司測算,2025年上半年恆指整體營收同比增速較去年同期顯著擡升,惟盈利增速或溫和放緩。

部分細分行業呈現信心增強趨勢,如新消費、科技與醫藥板塊,業績高增或大幅好轉預期下,財報披露前的盈利預期仍在上修,建議佈局業績預期向好且有良好確定性的板塊。

綜合來看,恆科2025年中報有望呈現“穩健爲主、向上有彈性”的格局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account